Posts

Genasys (GNSS) to Release Earnings on Tuesday

Genasys (NASDAQ:GNSS – Get Free Report) is projected to release its Q2 2025 earn...

Paramount Gold Nevada (PZG) Projected to Post Quarterly...

Paramount Gold Nevada (NYSEAMERICAN:PZG – Get Free Report) is projected to relea...

Actelis Networks (ASNS) Projected to Post Quarterly Ear...

Actelis Networks (NASDAQ:ASNS – Get Free Report) will likely be announcing its Q...

Ovid Therapeutics (OVID) Expected to Announce Quarterly...

Ovid Therapeutics (NASDAQ:OVID – Get Free Report) is anticipated to announce its...

Cellectar Biosciences (CLRB) Projected to Post Earnings...

Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) is anticipated to release ...

LiqTech International (LIQT) Expected to Announce Earni...

LiqTech International (NASDAQ:LIQT – Get Free Report) is anticipated to post its...

Synlogic (SYBX) Projected to Post Earnings on Tuesday

Synlogic (NASDAQ:SYBX – Get Free Report) is anticipated to issue its Q1 2025 qua...

Kyverna Therapeutics (KYTX) Projected to Post Quarterly...

Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) is expected to announce its...

Broadwind (BWEN) Projected to Post Quarterly Earnings o...

Broadwind (NASDAQ:BWEN – Get Free Report) is projected to release its Q1 2025 ea...

Dispatch from the Milken jamboree

Plus, Pimco’s warning, a US copper rush and the National Gallery’s rehang

Budget games, taxes and Treasuries

And greedflation revisited

Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Lower...

Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) had its price objective decre...

StockNews.com Upgrades Broadridge Financial Solutions (...

StockNews.com upgraded shares of Broadridge Financial Solutions (NYSE:BR – Free ...

Paramount Global (NASDAQ:PARA) Now Covered by StockNews...

StockNews.com began coverage on shares of Paramount Global (NASDAQ:PARA – Free R...

Abacus Life (NASDAQ:ABL) Price Target Raised to $12.00

Abacus Life (NASDAQ:ABL – Free Report) had its price objective boosted by Piper ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.